Download full-text PDF |
Source |
---|
Biomedicines
January 2025
Hemodialysis Unit, St. Marina Hospital, 5800 Pleven, Bulgaria.
Background: Chronic kidney disease (CKD) patients have an increased risk of cardiovascular disease (CVD), necessitating effective risk assessment methods. This study evaluates the calcium-phosphorus product (Ca × P) to estimated glomerular filtration rate (Ca × P/eGFR) ratio as a potential biomarker for predicting CV risk in pre-dialysis CKD patients.
Methods: Eighty-four CKD patients in stages G1-G4, according to the KDIGO criteria, were classified into CVD ( = 43) and non-CVD ( = 41) groups.
Ren Fail
December 2024
Division of Nephrology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
Clin Nephrol Case Stud
December 2023
Department of Ophthalmology, and.
Ther Adv Chronic Dis
June 2023
Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Background: The glomerular filtration rate (GFR) decline varies in patients with advanced chronic kidney disease (CKD), and the concurrent changes in CKD-related biomarkers are unclear.
Objectives: This study aimed to examine the changes in CKD-related biomarkers along with the kidney function decline in various GFR trajectory groups.
Design: This study was a longitudinal cohort study originated from the pre-end-stage renal disease (pre-ESRD) care program in a single tertiary center between 2006 and 2019.
Front Endocrinol (Lausanne)
April 2023
Department of Nephrology, Beijing Jishuitan Hospital, Beijing, China.
Background And Purpose: Sarcopenia is highly prevalent (28.5-40.3%) in patients undergoing hemodialysis and leads to poor clinical outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!